| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.2 | 6e-06 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.2 | 5e-05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |